Validea Guru Fundamental Report for CVS – 2/26/2023
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Below is Validea’s guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow, CVS rates highest using our Acquirer’s Multiple Investor model based on the published strategy of Tobias Carlisle. This deep value model looks for inexpensive stocks that c
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1451277892-5d6677cb7ffe42999ba03f993d1a1ba8.jpg "Are My Social Security Disability Benefits Taxable?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1358880761-82e600bfa20f4c2a8c48dc39cebeb0b0.jpg "<div>Accountant vs. Controller: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/Primary-Image-td-bank-cd-rates-march-2023-7482856-1d7d5a82f0ca496b9b1d63739cd7f567.jpg "TD Bank CD Rates: November 2024")